Teebi–Naguib–Al-Awadi Syndrome

Teebi–Naguib–Al-Awadi syndrome is a very rare, inherited birth-difference condition first described in families from Kuwait. Children are typically short for their age and have a recognizable pattern of facial traits (for example, wide-set eyes and a broad nose), hand and finger differences (short, broad hands; webbing between fingers; curved fifth fingers), and genital differences in boys (a “shawl” scrotum and sometimes undescended testes). Intelligence is usually normal, although mild developmental delay can occur in some children. Doctors recognized that this pattern ran in families with healthy, related parents, which points to autosomal recessive inheritance. cags.org.ae+2PMC+2

Teebi–Naguib–Al-Awadi syndrome is an ultra-rare genetic condition first described in Kuwaiti siblings and characterized by a constellation of facial features, hand and digital anomalies, short stature, and genital differences (notably a “shawl scrotum” in males). It follows autosomal recessive inheritance (both parents are typically unaffected carriers). Unlike better-known limb-reduction syndromes, this entity centers on facio-digitogenital findings rather than severe limb or pelvic aplasia. Because only a handful of families have been reported, prevalence is <1 per 1,000,000 and the full spectrum is still being defined. jmg.bmj.com+1

Researchers first reported an Arab family with five affected children who looked somewhat like Aarskog (facio-digitogenital) syndrome but with distinctive hair changes and a consistent set of hand and genital findings. Later, additional Kuwaiti Bedouin families were identified, confirming a separate, autosomal recessive facio-digito-genital syndrome—now known by the discoverers’ names (Teebi, Naguib, Al-Awadi). PMC+2jmg.bmj.com+2

---

Other names

Doctors and databases may use different labels for the same syndrome:

• Autosomal recessive facio-digito-genital syndrome (AR-FDG)

• Kuwait-type facio-digito-genital syndrome

• Teebi–Naguib–Al-Awadi syndrome (eponym)
  All three refer to the same clinical entity and were used in reports from Kuwait and in rare-disease catalogs. cags.org.ae+1

---

Types

There is no official “type 1 / type 2” classification. Clinicians instead talk about clinical spectrum or severity:

1. Classic Kuwait-type pattern. This is the picture first described: short stature, typical facial features, hand/foot changes, and, in males, a shawl scrotum. Hair can look dry or coarse with a widow’s peak. Intelligence is usually normal. cags.org.ae

2. Milder presentations. Some individuals show the facial pattern plus subtle hand changes and normal growth; boys may still have shawl scrotum. PMC

3. Sex-specific expression. Boys may show more obvious genital findings (shawl scrotum, undescended testes), while girls show the same facial and hand differences but, naturally, lack the scrotal feature. cags.org.ae

This “spectrum” framing mirrors how the original Kuwait families varied from child to child while sharing the same basic pattern. PMC

---

Causes

Because this is a genetic condition, “cause” refers to hereditary and biologic factors that make it more likely. The specific gene has not been conclusively established in the original reports; the pattern of inheritance, family clustering, and phenotypes are well documented.

1. Autosomal recessive inheritance. A child inherits one non-working copy of the responsible gene from each parent. cags.org.ae

2. Parents are healthy carriers. Each parent has one working and one non-working copy; they usually have no symptoms. cags.org.ae

3. 25% chance in each pregnancy for carrier parents to have an affected child. cags.org.ae

4. Consanguinity increases risk. When parents are related (e.g., cousins), they are more likely to carry the same rare variant. The Kuwait families were consanguineous. PMC

5. Founder effect. In small or historically isolated communities, a rare variant can become more common in descendants. The Bedouin families traced to a common ancestor. cags.org.ae

6. Random assortment of genes. Even in non-related parents, autosomal recessive conditions can occur by chance when both carry the same rare change. PMC

7. Biologic development of face, hands, and external genitalia. A single developmental pathway can affect all three regions, explaining the combined pattern. (This is an inference from clinical genetics, consistent with how syndromes cluster findings.) PMC

8. Variable expressivity. The same genetic change can look milder or more severe in different people. This was seen within the reported families. PMC

9. Possible modifier genes. Other genes can influence how strongly features appear, even with the same primary variant. (General principle in recessive syndromes.) PMC

10. Prenatal developmental timing. The facial, limb, and genital features form early in pregnancy; disruption in those windows yields the observed pattern. (General embryology principle applied to the syndrome’s organs.) PMC

11. Hair-follicle patterning trait. The widow’s-peak and hair texture reported suggest a developmental effect on hair-patterning. PMC

12. Cartilage/bone growth in digits. Middle-phalangeal underdevelopment reflects local growth signaling differences. cags.org.ae

13. Connective-tissue laxity. Hyperextensible hand joints point to connective-tissue involvement. cags.org.ae

14. Male external genital development. Shawl scrotum reflects altered scrotal skin attachment/migration during fetal life. cags.org.ae

15. Cryptorchidism risk. Undescended testes are common in genetic syndromes affecting genital development. cags.org.ae

16. Inguinal hernia predisposition. Weakness in the inguinal canal can co-occur with cryptorchidism and scrotal anomalies. cags.org.ae

17. Population genetics. Higher background carrier frequency can accumulate in a clan or tribe over time (related to founder effect). cags.org.ae

18. Non-environmental etiology. No environmental teratogen has been linked in the literature; the familial, recessive pattern supports a genetic cause. PMC

19. Recurrent risk for siblings. Because it’s recessive, each sibling of an affected child has a 25% chance to also be affected, if the same parents have more children. cags.org.ae

20. Carrier frequency in extended family. Relatives may carry the same variant, explaining multiple affected sibships in a large, extended pedigree. cags.org.ae

---

Symptoms and signs

I’ll describe each feature in everyday words, then list what clinicians saw in the original reports and summaries.

1. Short stature. Many children are shorter than their peers for age and sex when measured on growth charts. This was documented in most reported cases. cags.org.ae

2. Wide-set eyes (hypertelorism) or telecanthus. The eyes can look farther apart, or the inner eye distance is wide. This is part of the facial pattern. cags.org.ae

3. Broad forehead and broad nasal bridge. The upper face looks wide and the nose bridge is flat/broad. cags.org.ae

4. Short nose with up-turned nostrils (anteverted nares). The nose can look short with nostrils pointing slightly upward. cags.org.ae

5. Long, deep philtrum. The groove between the upper lip and nose is long/deep. cags.org.ae

6. Wide mouth with a full or protruding lower lip. The lower lip can look fuller and the mouth opening broader. cags.org.ae

7. Ear differences. Ears may sit slightly back (posteriorly rotated) or have small shape changes that are minor but noticeable to a clinician. cags.org.ae

8. Hair differences. Hair may be dry/coarse with a “widow’s peak.” This hair pattern was a clue that the condition was distinct from X-linked Aarskog syndrome. PMC

9. Hand size and shape. Hands are often small and broad; fingers may be short (brachydactyly). cags.org.ae

10. Finger webbing (mild syndactyly) and curved fifth fingers (clinodactyly). The skin between fingers may extend slightly; the pinky finger can curve toward the ring finger. cags.org.ae

11. Joint laxity in the hands. Finger joints can bend more than usual (hyperextensible), yet the tips may be a bit stiff (limited distal movement). cags.org.ae

12. Foot shape. Feet may be flat and broad with stubby toes; some children had metatarsus varus (inward-turned forefoot). cags.org.ae

13. Shawl scrotum (boys). The scrotal skin wraps forward under the penis like a shawl. This is a hallmark finding in males. cags.org.ae

14. Undescended testes and/or inguinal hernia (boys). Testes may not drop into the scrotum, and hernias in the groin can occur. cags.org.ae

15. Development and learning. Most children have normal intelligence; a minority may have mild developmental delay. Early reports emphasized normal cognition in many affected children. cags.org.ae

---

Diagnostic tests

Doctors combine a very careful physical exam with imaging and genetic testing. Because it’s very rare and overlaps with other conditions (especially Aarskog syndrome), specialists use tests to document features and exclude close look-alikes.

A) Physical examination (bedside assessment)

1. Structured dysmorphology exam. A clinical geneticist documents facial measurements (eye spacing, nasal bridge, philtrum length), hair pattern, ear rotation, and mouth features that match the syndrome’s pattern. This is the starting point. PMC+1

2. Hand and foot exam. The doctor looks for small/broad hands, webbing, brachydactyly, clinodactyly, joint laxity, and foot shape (flat, broad; toe pattern). These are defining clues. cags.org.ae

3. Genital exam in boys. The presence of a shawl scrotum, undescended testes, or a groin hernia supports the diagnosis. cags.org.ae

4. Growth charting. Height, weight, and head size are plotted; short stature is common in reports of the Kuwait type. cags.org.ae

5. Developmental screening. Simple tools (age-appropriate checklists) screen for mild delays while noting that most patients have normal intelligence. cags.org.ae

B) Manual/functional tests (simple clinic maneuvers)

6. Beighton score for joint laxity. A quick nine-point maneuver set that quantifies hyperextensibility in fingers and other joints; helpful when hand joints are lax. (General clinical practice for hypermobility.) cags.org.ae

7. Grip and pinch strength. Hand dynamometry checks function in short/broad hands and guides therapy if needed. (Standard hand-function assessment.) cags.org.ae

8. Range-of-motion mapping of fingers/toes. Clinicians document which joints bend/stiffen; useful when distal interphalangeal movement is limited. cags.org.ae

9. Gait and foot posture assessment. Observing standing and walking helps if feet are flat/broad or metatarsus varus is present. cags.org.ae

10. Vision and eye-alignment screening. Because eye spacing and eyelid slant can differ, clinicians screen for strabismus or refractive error. (Good practice in craniofacial patterns.) cags.org.ae

C) Laboratory and pathological tests

11. Chromosomal microarray (CMA). A genome-wide test that checks for gains/losses of DNA; used to rule out chromosomal syndromes that can mimic parts of the pattern. (Modern genetics workflow; original reports pre-dated CMA.) National Organization for Rare Disorders

12. Exome or genome sequencing. Looks for rare, recessive variants. Even though a single “known gene” wasn’t assigned in the earliest reports, modern sequencing helps with diagnosis in undifferentiated cases and excludes other look-alikes (such as X-linked Aarskog). National Organization for Rare Disorders

13. Targeted Aarskog/FDG gene testing (e.g., FGD1 for Aarskog). This helps confirm that the case is not classic X-linked Aarskog when the pattern instead fits the Kuwait-type autosomal recessive form. (Differential-diagnosis step drawn from the historical “Aarskog-like” origin.) PMC

14. Endocrine labs in boys with genital anomalies. If testes are undescended, physicians may check LH/FSH/testosterone baselines to guide urology/endocrine care, though hormone profiles are not diagnostic of the syndrome itself. (Standard care for cryptorchidism.) cags.org.ae

15. Basic metabolic/hematologic screen as part of a genetics work-up, mostly to exclude other conditions that can coexist with growth differences. (General genetics practice.) PMC

D) Electrodiagnostic tests

16. Auditory brainstem response (ABR) if needed. If hearing issues are suspected, ABR checks inner-ear/nerve function; it’s not a hallmark but is sometimes used in syndromic assessments. (Standard pediatric audiology.) PMC

17. Electrocardiogram (ECG) only if clinically indicated. Not a typical feature, but used when cardiac symptoms exist; included here to stress that testing is tailored to findings. (General pediatric genetics practice.) PMC

E) Imaging tests

18. Hand/foot X-rays. Radiographs can show short middle phalanges and other skeletal details that match the clinical picture. cags.org.ae

19. Pelvic and scrotal ultrasound in boys. Ultrasound helps find undescended testes, evaluate hernias, and plan surgery. (Standard urologic care.) cags.org.ae

20. Dental and craniofacial imaging as needed. Panoramic dental x-ray or craniofacial imaging may be used when palate or jaw concerns arise; this is supportive rather than diagnostic. (General craniofacial practice.) PMC

Non-pharmacological treatments (therapies and others)

1. Genetic counseling — Purpose: explain inheritance, recurrence risk, and testing options for relatives. Mechanism: clarifies autosomal recessive transmission and supports informed family planning. jmg.bmj.com+1

2. Multidisciplinary care coordination — Purpose: organize visits (genetics, pediatrics, orthopedics, craniofacial, urology). Mechanism: team-based plans reduce fragmented care and missed needs. Orpha

3. Growth and nutrition monitoring — Purpose: track height/weight and optimize calories and micronutrients. Mechanism: standardized growth charts and dietitian input support healthy growth despite short stature tendencies. Orpha

4. Physiotherapy for hand function — Purpose: improve grip, dexterity, and daily skills. Mechanism: task-oriented exercises and splinting enhance neuromuscular coordination and joint stability in atypical hand anatomy. jmg.bmj.com

5. Occupational therapy (OT) — Purpose: adapt school/home tasks (writing aids, utensils). Mechanism: activity analysis + assistive tools compensate for fine-motor differences. jmg.bmj.com

6. Speech-language evaluation if craniofacial differences affect articulation — Purpose: optimize speech clarity. Mechanism: targeted articulation therapy and oromotor exercises; referral if palatal issues suspected. jmg.bmj.com

7. Craniofacial/dental assessments — Purpose: address bite alignment, facial growth, and airway issues. Mechanism: orthodontic planning and periodic imaging guide timing of interventions. jmg.bmj.com

8. Urologic/andrology follow-up for shawl scrotum or other genital findings — Purpose: assess function, fertility potential, and surgical needs. Mechanism: physical exam + ultrasound; plan timing of corrective procedures if needed. jmg.bmj.com

9. Developmental surveillance — Purpose: confirm milestones and provide early educational supports if needed. Mechanism: standardized screens and school liaison. Orpha

10. Psychosocial support — Purpose: build resilience and body image confidence. Mechanism: counseling, peer groups, and family education. Orpha

11. Ergonomic classroom/home modifications — Purpose: reduce fatigue and strain. Mechanism: seating, pencil grips, keyboard alternatives, and rest breaks matched to hand differences. jmg.bmj.com

12. Orthotic support if joint laxity affects function — Purpose: stabilize wrists/fingers. Mechanism: custom splints assist alignment during tasks; periodic refit as the child grows. jmg.bmj.com

13. Regular ophthalmologic and audiology checks (if clinically indicated) — Purpose: detect treatable sensory issues early. Mechanism: screening improves learning and safety. Orpha

14. Physical activity plan — Purpose: maintain strength and cardiometabolic health. Mechanism: low-impact activities with hand-friendly adaptations preserve fitness safely. Orpha

15. Pain-minimization strategies without drugs — Purpose: ease occasional musculoskeletal discomfort. Mechanism: heat/cold, stretching, pacing, and ergonomics to reduce overuse. Orpha

16. Skin and scar care after any procedures — Purpose: optimize healing and appearance. Mechanism: wound care education; silicone gels or pressure garments per surgeon advice. Orpha

17. School individualized education plan (IEP) or 504 supports — Purpose: equitable access to education. Mechanism: accommodations for handwriting, testing time, and device use. Orpha

18. Dental hygiene coaching — Purpose: prevent caries if oral anatomy complicates brushing. Mechanism: adapted toothbrushes, fluoride, and regular cleanings. jmg.bmj.com

19. Family screening when there is consanguinity — Purpose: identify carrier status in relatives. Mechanism: targeted genetic testing where available. jmg.bmj.com

20. Transition-to-adult-care planning — Purpose: seamless care as teens age out of pediatrics. Mechanism: early transfer checklists and adult specialist referrals. Orpha

---

Drug treatments

Important: There are no FDA-approved drugs specifically for Teebi–Naguib–Al-Awadi syndrome. Medicines below are common supportive options used to treat everyday problems (e.g., pain, infection, hormonal deficiency) when clinically indicated for the individual. Doses and timing must be prescribed by a clinician. FDA label citations are provided to ground the drug information; indications are for their labeled uses, not for the syndrome itself.

1. Ibuprofen (NSAID) — Class: NSAID. Purpose: short-term relief of musculoskeletal pain or fever that may accompany overuse or intercurrent illness. Mechanism: COX inhibition reduces prostaglandins and inflammation. Typical OTC adult dosing is 200 mg per label directions; pediatric dosing is weight-based (clinical supervision essential). Side effects: GI upset/ulcer risk, renal effects, rare cardiovascular risks; avoid right before/after CABG. Label: Motrin/ibuprofen FDA label. FDA Access Data+2FDA Access Data+2

2. Acetaminophen (paracetamol) — Class: analgesic/antipyretic. Purpose: pain/fever when NSAIDs are unsuitable. Mechanism: central COX inhibition. Note: use exact dose limits to avoid liver toxicity. (If needed, clinicians reference the current FDA/OTC Drug Facts label; not all acetaminophen labels are hosted under a single NDA PDF on accessdata.)

3. Amoxicillin (when a routine bacterial infection is diagnosed) — Class: penicillin antibacterial. Purpose: treat otitis media, sinusitis, skin/respiratory infections per label. Mechanism: inhibits bacterial cell wall synthesis. Dosage is infection-specific and weight-based in children. Side effects: rash, GI upset; allergy precautions. Label: AMOXIL. FDA Access Data+1

4. Topical oral chlorhexidine (dental) — Class: antiseptic mouth rinse for gingivitis (if a dentist recommends). Purpose: adjunct to hygiene where anatomy complicates brushing. Mechanism: disrupts microbial membranes. (General label information is hosted on DailyMed; included here to illustrate supportive dental care; use per dentist and product label.)

5. Topical anesthetics (e.g., lidocaine gel for procedures per clinician) — Class: local anesthetic. Purpose: improve comfort during minor procedures or blood draws. Mechanism: sodium channel blockade. (Labels vary by product; medical supervision required.)

6. Testosterone cypionate (ONLY when a qualified clinician diagnoses hypogonadism in an adolescent/adult male) — Class: androgen. Purpose: physiologic hormone replacement if true deficiency is confirmed by testing; not cosmetic. Mechanism: restores androgen-receptor signaling for secondary sexual characteristics and anabolic effects. Dosing, monitoring (hematocrit, lipids, PSA in adults), and contraindications are critical. Side effects: erythrocytosis, acne, edema, mood changes. Label: Testosterone cypionate/Depo-Testosterone. FDA Access Data+2FDA Access Data+2

7. Estradiol (ONLY when a qualified clinician prescribes for a labeled indication, e.g., certain hypogonadal states in females after specialist evaluation) — Class: estrogen. Purpose: hormone replacement when medically indicated; requires risk–benefit discussion. Mechanism: estrogen receptor signaling. Risks include thromboembolism and other warnings; use lowest effective dose, shortest duration. Labels: Depo-Estradiol; estradiol transdermal system; VIVELLE-DOT. FDA Access Data+2FDA Access Data+2

8. Somatropin (human growth hormone) — only when formal testing shows growth hormone deficiency and a specialist indicates labeled use — Class: recombinant GH. Purpose: support linear growth for labeled indications only (e.g., GH deficiency). Mechanism: IGF-1–mediated growth effects. Requires careful dosing, surveillance for glucose intolerance and intracranial hypertension. Labels: GENOTROPIN; Norditropin; Saizen. FDA Access Data+2FDA Access Data+2

9. Topical emollients/barrier creams (skin care post-procedure) — Class: dermatologic protectants. Purpose: comfort and scar care per surgeon advice. Mechanism: occlusion and hydration. (OTC products; follow product labeling.)

10. Vitamin D with calcium (if deficient) — Class: nutritional supplement. Purpose: correct documented deficiency and support bone health. Mechanism: improves calcium absorption and bone mineralization. (OTC; use per clinician lab results and product label.)

11. Ferrous sulfate (if iron deficiency is documented) — Class: oral iron. Purpose: correct anemia that could worsen fatigue. Mechanism: replenishes iron stores. Side effects: GI upset/constipation; dose by elemental iron. (OTC/DailyMed labeling varies.)

12. Antihistamines for allergic rhinitis that worsens sleep or feeding — Class: H1 blockers. Purpose: symptomatic allergy relief. Mechanism: histamine receptor blockade. (OTC labels vary; pediatric dosing needs clinician guidance.)

13. Proton-pump inhibitor or H2 blocker (short-term, if gastroesophageal reflux is diagnosed) — Purpose: reduce acid-related symptoms that may aggravate feeding/sleep. Mechanism: acid suppression. (Prescription/OTC labels vary; use only for confirmed indications.)

14. Topical antibiotic ointment (minor wound care per clinician) — Purpose: prevent superficial infection after small procedures. Mechanism: local antibacterial effect. (OTC labels vary.)

15. Acetaminophen–ibuprofen alternating plan — Purpose: fever/pain control during intercurrent illnesses, when appropriate. Mechanism: complementary analgesic pathways. Labels: see ibuprofen FDA label references; acetaminophen per OTC Drug Facts. FDA Access Data+2FDA Access Data+2

16. Short-course oral antibiotics (per culture) for dental or skin infections — Purpose: treat proven bacterial infections. Mechanism: pathogen-directed therapy (e.g., amoxicillin). Label: AMOXIL. FDA Access Data

17. Intranasal saline — Purpose: non-drug congestion relief to aid sleep/feeding. Mechanism: mechanical clearance. (OTC.)

18. Topical fluoride (dental) — Purpose: enamel strengthening if enamel quality and brushing are challenged. Mechanism: remineralization. (Use per dentist.)

19. Stool softener (if constipation from limited mobility or iron) — Purpose: improve comfort and adherence to iron if needed. Mechanism: osmosis/lubrication. (OTC labels vary; clinician advice required for children.)

20. Peri-operative analgesia/anesthesia protocols — Purpose: safe pain control during surgeries (below). Mechanism: multimodal, weight-based regimens. Label anchor for NSAID segment: ibuprofen FDA label. FDA Access Data

Safety note: Items above are examples used for common problems; they’re not a standing regimen for this syndrome. A specialist must individualize decisions, particularly any hormone therapy or somatropin, which have strict diagnostic and monitoring requirements on their labels. FDA Access Data+1

---

Dietary molecular supplements

1. Vitamin D3 — Dose per blood levels (often 600–1000 IU/day in older children/adults unless higher repletion is needed). Function: supports bone mineralization. Mechanism: increases intestinal calcium absorption. Use only with labs and clinician guidance.

2. Calcium — Dose tailored to age/dietary intake. Function: bone/teeth strength. Mechanism: mineral substrate for bone.

3. Iron (elemental) — Dose per ferritin/TSAT. Function: corrects iron-deficiency anemia. Mechanism: hemoglobin synthesis.

4. Vitamin B12 — Dose if low. Function: red blood cell and nerve health. Mechanism: cofactor in DNA synthesis.

5. Folate — Dose if low. Function: cell division and growth. Mechanism: one-carbon metabolism.

6. Zinc — Dose if low or poor intake. Function: wound healing and immune enzyme function. Mechanism: cofactor for many proteins.

7. Iodine — Dose within RDA if diet lacks iodized salt. Function: thyroid hormone production. Mechanism: thyroid substrate.

8. Magnesium — Function: muscle/nerve function; supports bone. Mechanism: enzyme cofactor; use within RDA.

9. Omega-3 (EPA/DHA) — Function: general cardio-neuro support and anti-inflammatory balance. Mechanism: membrane lipid and eicosanoid modulation.

10. Multivitamin (age-appropriate) — Function: broad micronutrient coverage if diet is limited. Mechanism: prevents subclinical deficiencies.

Supplements aren’t disease-specific treatments; they fill nutritional gaps. Over-supplementation can be harmful—dosing should match labs and dietary assessment.

---

Immunity-booster / regenerative / stem-cell” drug concepts

There are no FDA-approved immune-booster or regenerative/stem-cell drugs for Teebi–Naguib–Al-Awadi syndrome, and such products should not be used outside regulated trials. When families hear these terms, what usually helps is optimized nutrition, vaccination, and treating intercurrent illnesses promptly. Any consideration of growth hormone or sex hormone replacement must follow the strict labeled indications (above). FDA Access Data+1

---

Surgeries (procedures and why they’re done)

1. Genital reconstructive procedures (e.g., correction of shawl scrotum; repair of hypospadias if present) — Why: improve function, hygiene, and body image; timed with growth. jmg.bmj.com

2. Orchiopexy (if cryptorchidism is present) — Why: protect fertility potential and lower torsion/malignancy risk; usually done in early childhood per urologic guidelines. jmg.bmj.com

3. Hand surgery (selected cases) — Why: release syndactyly or correct deformities that limit daily function; followed by hand therapy. jmg.bmj.com

4. Craniofacial procedures/orthodontics — Why: optimize bite, speech resonance, and facial growth when anatomy warrants. jmg.bmj.com

5. Dental/oral surgeries — Why: address crowding, impacted teeth, or palatal issues that impair function or hygiene. jmg.bmj.com

---

Preventions

1. Regular genetics-guided follow-up to anticipate age-related needs. Orpha

2. Vaccinations on schedule to reduce infection burden.

3. Early dental care to prevent caries. jmg.bmj.com

4. Safe physical activity plan to avoid overuse injuries. Orpha

5. Ergonomic aids for school/work to prevent strain. jmg.bmj.com

6. Nutrition with sufficient protein, calcium, vitamin D.

7. Prompt treatment of infections to avoid complications. FDA Access Data

8. Skin/wound care education after any procedures.

9. Mental-health and peer support to reduce stigma and isolation. Orpha

10. Family planning counseling for adult relatives/carriers. Orpha

---

When to see doctors (red-flags)

• New pain, swelling, fever, or wound problems after any surgery.

• Feeding, sleep, or school performance difficulties that persist despite home strategies.

• Signs of hormone issues (e.g., delayed puberty) — need endocrinology/urology assessment before considering any replacement therapy. FDA Access Data+1

• Dental pain or bleeding gums — see dentist early. jmg.bmj.com

---

What to eat (and avoid) in simple words

Eat: balanced meals with lean protein, whole grains, dairy or fortified alternatives (for calcium), and fruit/vegetables for vitamins. Include sources of vitamin D (fortified foods) and consider iodized salt if diet is low in iodine. Drink water and keep regular meals to support growth and activity.

Avoid/expose carefully: excessive sugary drinks (dental risk), ultra-processed snacks crowding out nutrients, and megadose supplements unless prescribed. If iron supplements are used for deficiency, avoid tea/coffee with the dose (blocks absorption) and pair iron with vitamin C–containing foods. (General nutrition guidance; a dietitian can tailor plans.)

---

Frequently asked questions

1. Is this the same as Al-Awadi/Raas-Rothschild syndrome? No—those cases have severe limb/pelvis hypoplasia and often WNT7A variants; Teebi–Naguib–Al-Awadi is a facio-digitogenital pattern. Cell+1

2. How is it inherited? Autosomal recessive; parents are generally healthy carriers. jmg.bmj.com

3. Is intelligence usually affected? Reports describe normal intelligence, but developmental checks are still recommended. jmg.bmj.com

4. Is there a gene test? No single known gene has been confirmed; exome testing helps exclude look-alikes and discover variants in research. Orpha

5. What is the outlook? With supportive care, many challenges are manageable; long-term data are limited due to rarity. Orpha

6. Are there approved medicines for this syndrome? No—treatments are symptom-based (e.g., infection management, pain relief, dental care). FDA Access Data+1

7. Can growth hormone help short stature? Only if a specialist confirms growth hormone deficiency under labeled indications; otherwise it’s not appropriate. FDA Access Data

8. Can hormone therapy fix genital differences? Hormones are used only for proven hypogonadism or other labeled indications; structural differences often need surgery. FDA Access Data

9. What surgeries are common? Procedures may address shawl scrotum, cryptorchidism, and hand/craniofacial issues that affect function or hygiene. jmg.bmj.com

10. Will my child need special schooling? Many children do well with standard schooling plus simple accommodations (OT tools, extra time). Orpha

11. Should siblings be tested? Genetic counseling can discuss carrier testing for older siblings and relatives. Orpha

12. Is pain common? Chronic pain isn’t a primary feature; activity-related aches can be handled with ergonomics and occasional analgesics when appropriate. FDA Access Data

13. Are there clinical trials? Given the rarity, trials are uncommon; registries and exome programs may exist through rare-disease centers. Orpha

14. What about fertility? Depends on individual anatomy and endocrine findings; urology/gynecology can advise over time. jmg.bmj.com

15. How do we plan for adulthood? Start a transition plan in early adolescence to hand off to adult specialists smoothly. Orpha

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 07, 2025.